Insider
Date
Role
Action
Shares
Price
Amount
Kamal Adawi
3 Nov 2026
Chief Financial Officer
Sell
6,582
$2.05
$13.52K
Bahram Valamehr
4 Aug 2026
President and CEO
Sell
43,947
$2.46
$108.10K
Cindy Tahl
4 Aug 2026
See Remarks
Sell
38,800
$2.46
$95.41K
Bahram Valamehr
20 May 2026
President and CEO
Sell
28,946
$1.88
$54.48K
Cindy Tahl
20 May 2026
See Remarks
Sell
25,590
$1.88
$48.08K
Cindy Tahl
6 May 2026
See Remarks
Exercised, kept
44,444
$1.05
$46.67K
Cindy Tahl
6 May 2026
See Remarks
Exercised, kept
122,220
$1.32
$161.33K
William H Rastetter
5 May 2026
Director
Exercised, kept
25,000
$1.69
$42.25K
Robert S Epstein
5 May 2026
Director
Exercised, kept
25,000
$1.69
$42.25K
Bahram Valamehr
9 Jan 2026
President and CEO
Sell
5,190
$1.07
$5.56K
Cindy Tahl
9 Jan 2026
See Remarks
Sell
10,589
$1.06
$11.28K
Bahram Valamehr
4 Aug 2025
President and CEO
Sell
14,466
$1.06
$15.40K
Cindy Tahl
4 Aug 2025
See Remarks
Sell
9,037
$1.06
$9.57K
Bahram Valamehr
10 Jan 2025
President and CEO
Sell
8,705
$1.54
$13.41K
Cindy Tahl
10 Jan 2025
See Remarks
Sell
5,654
$1.55
$8.76K
Jerome Charles Bressi
10 Jan 2025
See Remarks
Sell
5,980
$1.55
$9.27K
Redmile Group, LLC
20 Dec 2024
Director
Buy
indirect
397,964
$1.68
$668.58K
Redmile Group, LLC
20 Dec 2024
Director
Sell
indirect
341,633
$1.68
$573.94K
Yuan Xu
6 Aug 2024
Director
Sold on a plan
633
$4.23
$2.68K
Edward J Dulac III
4 Mar 2024
Chief Financial Officer
Sold on a plan
2,447
$7.77
$19.01K
Edward J Dulac III
29 Jan 2024
Chief Financial Officer
Sold on a plan
1,849
$5.00
$9.25K
Edward J Dulac III
9 Jan 2024
Chief Financial Officer
Sell
7,028
$4.37
$30.71K
J Scott Wolchko
9 Jan 2024
President and CEO
Sell
14,391
$4.37
$62.89K
Bahram Valamehr
9 Jan 2024
Chief R&D Officer
Sell
11,271
$4.38
$49.37K
Cindy Tahl
9 Jan 2024
General Counsel and Secretary
Sell
10,874
$4.37
$47.52K
Edward J Dulac III
2 Jan 2024
Chief Financial Officer
Sold on a plan
5,182
$3.66
$18.97K
Redmile Group, LLC
26 Dec 2023
Director
Buy
indirect
44,630
$3.72
$166.02K
Edward J Dulac III
18 Dec 2023
Chief Financial Officer
Sold on a plan
1,585
$3.50
$5.55K
Cindy Tahl
9 Nov 2023
General Counsel and Secretary
Sold on a plan
24,363
$2.40
$58.47K
Edward J Dulac III
18 Aug 2023
Chief Financial Officer
Sell
4,718
$2.80
$13.21K
Yuan Xu
4 Aug 2023
Director
Sold on a plan
632
$3.71
$2.34K
Edward J Dulac III
5 Jul 2023
Chief Financial Officer
Sold on a plan
5,182
$4.83
$25.03K
Brian T. Powl
5 Jul 2023
Chief Commercial Officer
Sell
3,854
$4.87
$18.77K
Yuan Xu
14 Jun 2023
Director
Sold on a plan
3,460
$5.58
$19.31K
Redmile Group, LLC
21 Apr 2023
Director
Buy
indirect
256,639
$6.18
$1.59M
Redmile Group, LLC
20 Apr 2023
Director
Buy
indirect
20,000
$5.99
$119.80K
Yu-Waye Chu
18 Apr 2023
Chief Medical Officer
Sold on a plan
2,317
$6.58
$15.25K
Yu-Waye Chu
18 Apr 2023
Chief Medical Officer
Sold on a plan
215
$6.52
$1.40K
Redmile Group, LLC
14 Apr 2023
Director
Buy
indirect
25,700
$6.00
$154.20K
Redmile Group, LLC
14 Apr 2023
Director
Sell
indirect
302,339
$5.84
$1.77M
John Mendlein
19 Jan 2023
Director
Exercised, kept
28,461
$1.37
$38.99K
John Mendlein
13 Jan 2023
Director
Buy
36,631
$5.43
$198.91K
Bahram Valamehr
12 Jan 2023
Chief R&D Officer
Exercised, kept
423
$1.37
$579.51
John Mendlein
11 Jan 2023
Director
Buy
88,048
$5.67
$499.23K
Yu-Waye Chu
10 Jan 2023
Chief Medical Officer
Sell
7,825
$5.24
$41.00K
Edward J Dulac III
10 Jan 2023
Chief Financial Officer
Sell
7,331
$5.24
$38.41K
Mark Plavsic
10 Jan 2023
Chief Technical Officer
Sell
3,418
$5.24
$17.91K
Cindy Tahl
10 Jan 2023
General Counsel and Secretary
Sell
11,553
$5.24
$60.54K
Bahram Valamehr
10 Jan 2023
Chief R&D Officer
Sell
10,917
$5.24
$57.21K
J Scott Wolchko
10 Jan 2023
President and CEO
Sell
45,907
$5.24
$240.55K
Edward J Dulac III
18 Aug 2022
Chief Financial Officer
Sell
432
$30.41
$13.14K
Edward J Dulac III
18 Aug 2022
Chief Financial Officer
Sell
4,703
$29.75
$139.91K
J Scott Wolchko
22 Jul 2022
President and CEO
Sold after exercise
620
$33.28
$20.63K
J Scott Wolchko
22 Jul 2022
President and CEO
Sold after exercise
2,703
$32.61
$88.14K
J Scott Wolchko
22 Jul 2022
President and CEO
Sold after exercise
2,923
$31.33
$91.58K
J Scott Wolchko
21 Jul 2022
President and CEO
Sold after exercise
19,171
$33.07
$633.98K
J Scott Wolchko
21 Jul 2022
President and CEO
Sold after exercise
10,829
$32.54
$352.38K
Bahram Valamehr
7 Jul 2022
Chief R&D Officer
Sold after exercise
17,158
$30.23
$518.69K
Bahram Valamehr
6 Jul 2022
Chief R&D Officer
Sold after exercise
7,842
$30.07
$235.81K
Mark Plavsic
5 Jul 2022
Chief Technical Officer
Sell
3,719
$24.61
$91.52K
Shefali Agarwal
7 Jun 2022
Director
Sell
841
$21.89
$18.41K
Shefali Agarwal
3 Jun 2022
Director
Sell
807
$22.80
$18.40K
Timothy Coughlin
3 Jun 2022
Director
Sell
1,439
$22.81
$32.82K
Robert Hershberg
3 Jun 2022
Director
Sell
672
$22.75
$15.29K
Karin Jooss
3 Jun 2022
Director
Sell
1,483
$22.82
$33.84K
John Mendlein
3 Jun 2022
Director
Sell
1,364
$22.79
$31.09K
Cindy Tahl
1 Jun 2022
General Counsel and Secretary
Sold after exercise
25,000
$22.96
$574.00K
J Scott Wolchko
22 Apr 2022
President and CEO
Sold after exercise
838
$35.15
$29.46K
J Scott Wolchko
22 Apr 2022
President and CEO
Sold after exercise
9,162
$34.54
$316.46K
J Scott Wolchko
21 Apr 2022
President and CEO
Sold after exercise
1,003
$37.90
$38.01K
J Scott Wolchko
21 Apr 2022
President and CEO
Sold after exercise
2,220
$36.70
$81.47K
J Scott Wolchko
21 Apr 2022
President and CEO
Sold after exercise
4,062
$35.73
$145.14K
J Scott Wolchko
21 Apr 2022
President and CEO
Sold after exercise
22,715
$34.57
$785.26K
Yu-Waye Chu
19 Apr 2022
Chief Medical Officer
Sell
4,062
$35.37
$143.67K
Cindy Tahl
1 Apr 2022
General Counsel and Secretary
Sold after exercise
25,000
$38.85
$971.25K
Bahram Valamehr
14 Mar 2022
Chief R&D Officer
Sold after exercise
100
$34.04
$3.40K
Bahram Valamehr
14 Mar 2022
Chief R&D Officer
Sold after exercise
2,960
$33.30
$98.57K
Bahram Valamehr
14 Mar 2022
Chief R&D Officer
Sold after exercise
2,195
$32.49
$71.32K
Bahram Valamehr
14 Mar 2022
Chief R&D Officer
Sold after exercise
3,067
$31.66
$97.10K
Bahram Valamehr
14 Mar 2022
Chief R&D Officer
Sold after exercise
16,678
$30.36
$506.34K
John Mendlein
10 Mar 2022
Director
Sold after exercise
12,069
$35.48
$428.21K
John Mendlein
10 Mar 2022
Director
Sold after exercise
19,493
$34.73
$676.99K
J Scott Wolchko
21 Jan 2022
President and CEO
Sold after exercise
10,000
$38.02
$380.20K
J Scott Wolchko
20 Jan 2022
President and CEO
Sold after exercise
30,000
$40.21
$1.21M
Yu-Waye Chu
11 Jan 2022
Senior VP Clinical Development
Sell
418
$49.10
$20.52K
Yu-Waye Chu
11 Jan 2022
Senior VP Clinical Development
Sell
3,547
$48.44
$171.82K
Edward J Dulac III
11 Jan 2022
Chief Financial Officer
Sell
390
$49.16
$19.17K
Edward J Dulac III
11 Jan 2022
Chief Financial Officer
Sell
1,380
$48.25
$66.59K
Bahram Valamehr
11 Jan 2022
Chief R&D Officer
Sell
418
$49.12
$20.53K
Bahram Valamehr
11 Jan 2022
Chief R&D Officer
Sell
4,152
$48.44
$201.12K
Cindy Tahl
11 Jan 2022
General Counsel and Secretary
Sell
536
$49.15
$26.34K
Cindy Tahl
11 Jan 2022
General Counsel and Secretary
Sell
4,883
$48.46
$236.63K
J Scott Wolchko
11 Jan 2022
President and CEO
Sell
4,519
$49.07
$221.75K
J Scott Wolchko
11 Jan 2022
President and CEO
Sell
10,047
$48.50
$487.28K
Bahram Valamehr
10 Jan 2022
Chief R&D Officer
Sell
351
$47.17
$16.56K
Bahram Valamehr
10 Jan 2022
Chief R&D Officer
Sell
5,245
$46.33
$243.00K
Cindy Tahl
10 Jan 2022
General Counsel and Secretary
Sell
643
$47.15
$30.32K
Cindy Tahl
10 Jan 2022
General Counsel and Secretary
Sell
7,095
$46.37
$329.00K
J Scott Wolchko
10 Jan 2022
President and CEO
Sell
101
$47.72
$4.82K
J Scott Wolchko
10 Jan 2022
President and CEO
Sell
20,894
$47.17
$985.57K
J Scott Wolchko
10 Jan 2022
President and CEO
Sell
13,161
$46.36
$610.14K
Cindy Tahl
3 Jan 2022
General Counsel and Secretary
Sold after exercise
861
$60.31
$51.93K
Cindy Tahl
3 Jan 2022
General Counsel and Secretary
Sold after exercise
27,812
$59.86
$1.66M
Cindy Tahl
3 Jan 2022
General Counsel and Secretary
Sold after exercise
16,900
$58.84
$994.40K
Cindy Tahl
3 Jan 2022
General Counsel and Secretary
Sold after exercise
4,427
$57.76
$255.70K
Edward J Dulac III
20 Dec 2021
Chief Financial Officer
Sold after exercise
15,977
$60.00
$958.62K
Bahram Valamehr
13 Dec 2021
Chief R&D Officer
Sold after exercise
1,600
$49.27
$78.83K
Bahram Valamehr
13 Dec 2021
Chief R&D Officer
Sold after exercise
7,718
$48.75
$376.25K
Bahram Valamehr
13 Dec 2021
Chief R&D Officer
Sold after exercise
6,564
$47.61
$312.51K
Bahram Valamehr
13 Dec 2021
Chief R&D Officer
Sold after exercise
7,018
$46.72
$327.88K
Bahram Valamehr
13 Dec 2021
Chief R&D Officer
Sold after exercise
2,100
$45.68
$95.93K
Yu-Waye Chu
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
5
$55.54
$277.70
Yu-Waye Chu
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
600
$54.58
$32.75K
Yu-Waye Chu
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
1,031
$53.66
$55.32K
Yu-Waye Chu
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
1,822
$52.37
$95.42K
Yu-Waye Chu
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
1,045
$51.08
$53.38K
Yu-Waye Chu
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
900
$50.42
$45.38K
Yu-Waye Chu
10 Dec 2021
Senior VP Clinical Development
Sold after exercise
2,097
$49.32
$103.42K
J Scott Wolchko
18 Nov 2021
President and CEO
Sold after exercise
20,000
$54.27
$1.09M
J Scott Wolchko
22 Oct 2021
President and CEO
Sold after exercise
30,000
$58.88
$1.77M
J Scott Wolchko
21 Oct 2021
President and CEO
Sold after exercise
14,765
$60.63
$895.20K
J Scott Wolchko
21 Oct 2021
President and CEO
Sold after exercise
15,235
$59.82
$911.36K
Cindy Tahl
1 Oct 2021
General Counsel and Secretary
Sold after exercise
11,844
$59.68
$706.86K
Cindy Tahl
1 Oct 2021
General Counsel and Secretary
Sold after exercise
21,844
$58.96
$1.29M
Cindy Tahl
1 Oct 2021
General Counsel and Secretary
Sold after exercise
16,312
$58.03
$946.63K
Edward J Dulac III
28 Sep 2021
Chief Financial Officer
Sold after exercise
19,460
$62.53
$1.22M
Bahram Valamehr
13 Sep 2021
Chief Development Officer
Sold after exercise
800
$67.46
$53.96K
Bahram Valamehr
13 Sep 2021
Chief Development Officer
Sold after exercise
8,391
$66.84
$560.88K
Bahram Valamehr
13 Sep 2021
Chief Development Officer
Sold after exercise
15,809
$65.94
$1.04M
Edward J Dulac III
19 Aug 2021
Chief Financial Officer
Sell
63
$90.00
$5.67K
Edward J Dulac III
19 Aug 2021
Chief Financial Officer
Sell
1,474
$88.65
$130.67K
Edward J Dulac III
19 Aug 2021
Chief Financial Officer
Sell
1,937
$87.90
$170.26K
J Scott Wolchko
19 Aug 2021
President and CEO
Sold after exercise
20,000
$88.01
$1.76M
J Scott Wolchko
23 Jul 2021
President and CEO
Sold after exercise
30,000
$85.28
$2.56M
J Scott Wolchko
22 Jul 2021
President and CEO
Sold after exercise
1,600
$86.90
$139.04K
J Scott Wolchko
22 Jul 2021
President and CEO
Sold after exercise
21,773
$86.19
$1.88M
J Scott Wolchko
22 Jul 2021
President and CEO
Sold after exercise
6,627
$85.38
$565.82K
Cindy Tahl
1 Jul 2021
General Counsel and Secretary
Sold after exercise
50,000
$84.56
$4.23M
Cindy Tahl
1 Jul 2021
General Counsel and Secretary
Sold after exercise
100
$95.30
$9.53K
Cindy Tahl
1 Jul 2021
General Counsel and Secretary
Sold after exercise
1,825
$94.63
$172.69K
Cindy Tahl
1 Jul 2021
General Counsel and Secretary
Sold after exercise
400
$93.31
$37.32K
Cindy Tahl
1 Jul 2021
General Counsel and Secretary
Sold after exercise
432
$92.26
$39.86K
Cindy Tahl
1 Jul 2021
General Counsel and Secretary
Sold after exercise
225
$91.06
$20.49K
Cindy Tahl
1 Jul 2021
General Counsel and Secretary
Sold after exercise
707
$90.30
$63.84K
Cindy Tahl
1 Jul 2021
General Counsel and Secretary
Sold after exercise
400
$88.93
$35.57K
Cindy Tahl
1 Jul 2021
General Counsel and Secretary
Sold after exercise
1,145
$87.90
$100.64K
Cindy Tahl
1 Jul 2021
General Counsel and Secretary
Sold after exercise
200
$86.56
$17.31K
Cindy Tahl
1 Jul 2021
General Counsel and Secretary
Sold after exercise
100
$84.83
$8.48K
Bahram Valamehr
14 Jun 2021
Chief Development Officer
Sold after exercise
400
$90.76
$36.30K
Bahram Valamehr
14 Jun 2021
Chief Development Officer
Sold after exercise
8,220
$89.68
$737.15K
Bahram Valamehr
14 Jun 2021
Chief Development Officer
Sold after exercise
16,380
$89.11
$1.46M
J Scott Wolchko
20 May 2021
President and CEO
Sold after exercise
20,000
$77.16
$1.54M
J Scott Wolchko
23 Apr 2021
President and CEO
Sold after exercise
30,000
$85.24
$2.56M
J Scott Wolchko
22 Apr 2021
President and CEO
Sold after exercise
30,000
$85.54
$2.57M
Yu-Waye Chu
16 Apr 2021
Senior VP Clinical Development
Sell
1,500
$84.41
$126.62K
Yu-Waye Chu
16 Apr 2021
Senior VP Clinical Development
Sell
900
$82.91
$74.62K
Yu-Waye Chu
16 Apr 2021
Senior VP Clinical Development
Sell
875
$81.80
$71.58K
Cindy Tahl
1 Apr 2021
See Remarks
Sold after exercise
400
$87.45
$34.98K
Cindy Tahl
1 Apr 2021
See Remarks
Sold after exercise
5,299
$86.76
$459.73K
Cindy Tahl
1 Apr 2021
See Remarks
Sold after exercise
4,835
$85.98
$415.73K
Cindy Tahl
1 Apr 2021
See Remarks
Sold after exercise
2,200
$84.48
$185.87K
Cindy Tahl
1 Apr 2021
See Remarks
Sold after exercise
3,490
$83.40
$291.08K
Cindy Tahl
1 Apr 2021
See Remarks
Sold after exercise
4,556
$82.69
$376.71K
Cindy Tahl
1 Apr 2021
See Remarks
Sold after exercise
8,220
$81.48
$669.73K
Cindy Tahl
1 Apr 2021
See Remarks
Sold after exercise
1,000
$80.49
$80.49K
Bahram Valamehr
15 Mar 2021
Chief Development Officer
Sold after exercise
1,018
$94.59
$96.30K
Bahram Valamehr
15 Mar 2021
Chief Development Officer
Sold after exercise
3,205
$93.75
$300.46K
Bahram Valamehr
15 Mar 2021
Chief Development Officer
Sold after exercise
8,404
$92.64
$778.58K
Bahram Valamehr
15 Mar 2021
Chief Development Officer
Sold after exercise
8,416
$91.94
$773.78K
Bahram Valamehr
15 Mar 2021
Chief Development Officer
Sold after exercise
3,957
$90.89
$359.65K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
800
$86.70
$69.36K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
2,900
$85.50
$247.96K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
2,728
$84.20
$229.70K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
2,480
$83.46
$206.99K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
2,993
$81.60
$244.22K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
5,174
$80.73
$417.72K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
4,627
$79.58
$368.24K
Daniel D Shoemaker
8 Mar 2021
Chief Scientific Officer
Sell
3,298
$78.60
$259.24K
J Scott Wolchko
18 Feb 2021
President and CEO
Sold after exercise
5,547
$103.16
$572.21K
J Scott Wolchko
18 Feb 2021
President and CEO
Sold after exercise
8,602
$102.26
$879.66K
J Scott Wolchko
18 Feb 2021
President and CEO
Sold after exercise
2,602
$101.42
$263.88K
J Scott Wolchko
18 Feb 2021
President and CEO
Sold after exercise
1,848
$100.48
$185.69K
J Scott Wolchko
18 Feb 2021
President and CEO
Sold after exercise
1,401
$99.08
$138.82K
J Scott Wolchko
22 Jan 2021
President and CEO
Sold after exercise
3,075
$100.01
$307.54K
J Scott Wolchko
22 Jan 2021
President and CEO
Sold after exercise
6,520
$99.35
$647.73K
J Scott Wolchko
22 Jan 2021
President and CEO
Sold after exercise
7,638
$98.45
$751.95K
J Scott Wolchko
22 Jan 2021
President and CEO
Sold after exercise
12,767
$97.23
$1.24M
J Scott Wolchko
21 Jan 2021
President and CEO
Sold after exercise
200
$106.96
$21.39K
J Scott Wolchko
21 Jan 2021
President and CEO
Sold after exercise
645
$106.03
$68.39K
J Scott Wolchko
21 Jan 2021
President and CEO
Sold after exercise
4,271
$105.25
$449.52K
J Scott Wolchko
21 Jan 2021
President and CEO
Sold after exercise
9,156
$104.13
$953.44K
J Scott Wolchko
21 Jan 2021
President and CEO
Sold after exercise
3,895
$103.23
$402.09K
J Scott Wolchko
21 Jan 2021
President and CEO
Sold after exercise
3,300
$101.91
$336.31K
J Scott Wolchko
21 Jan 2021
President and CEO
Sold after exercise
5,993
$101.09
$605.81K
J Scott Wolchko
21 Jan 2021
President and CEO
Sold after exercise
2,540
$100.16
$254.41K
Cindy Tahl
19 Jan 2021
General Counsel and Secretary
Sold after exercise
200
$117.07
$23.41K
Cindy Tahl
19 Jan 2021
General Counsel and Secretary
Sold after exercise
4,021
$115.97
$466.33K
Cindy Tahl
19 Jan 2021
General Counsel and Secretary
Sold after exercise
14,944
$115.09
$1.72M
Cindy Tahl
19 Jan 2021
General Counsel and Secretary
Sold after exercise
15,835
$114.11
$1.81M
Daniel D Shoemaker
11 Jan 2021
Chief Scientific Officer
Sell
871
$109.65
$95.51K
Daniel D Shoemaker
11 Jan 2021
Chief Scientific Officer
Sell
1,050
$110.76
$116.30K
Daniel D Shoemaker
11 Jan 2021
Chief Scientific Officer
Sell
1,332
$111.62
$148.67K
Cindy Tahl
11 Jan 2021
General Counsel and Secretary
Sell
872
$109.65
$95.62K
Cindy Tahl
11 Jan 2021
General Counsel and Secretary
Sell
1,050
$110.76
$116.30K
Cindy Tahl
11 Jan 2021
General Counsel and Secretary
Sell
1,332
$111.62
$148.67K
Bahram Valamehr
11 Jan 2021
Chief Development Officer
Sell
871
$109.65
$95.51K
Bahram Valamehr
11 Jan 2021
Chief Development Officer
Sell
1,051
$110.76
$116.41K
Bahram Valamehr
11 Jan 2021
Chief Development Officer
Sell
1,332
$111.62
$148.67K
J Scott Wolchko
11 Jan 2021
President and CEO
Sell
2,300
$109.65
$252.20K
J Scott Wolchko
11 Jan 2021
President and CEO
Sell
2,772
$110.76
$307.02K
J Scott Wolchko
11 Jan 2021
President and CEO
Sell
3,515
$111.62
$392.33K
Redmile Group, LLC
8 Jan 2021
Director
Buy
indirect
327,485
$85.50
$28.00M
Daniel D Shoemaker
8 Jan 2021
Chief Scientific Officer
Sell
151
$114.76
$17.33K
Daniel D Shoemaker
8 Jan 2021
Chief Scientific Officer
Sell
872
$115.80
$100.98K
Daniel D Shoemaker
8 Jan 2021
Chief Scientific Officer
Sell
2,451
$117.15
$287.14K
Daniel D Shoemaker
8 Jan 2021
Chief Scientific Officer
Sell
2,755
$117.60
$323.99K
Cindy Tahl
8 Jan 2021
General Counsel and Secretary
Sell
151
$114.76
$17.33K
Cindy Tahl
8 Jan 2021
General Counsel and Secretary
Sell
872
$115.80
$100.98K
Cindy Tahl
8 Jan 2021
General Counsel and Secretary
Sell
2,451
$117.15
$287.14K
Cindy Tahl
8 Jan 2021
General Counsel and Secretary
Sell
2,755
$117.60
$323.99K
Bahram Valamehr
8 Jan 2021
Chief Development Officer
Sell
151
$114.76
$17.33K
Bahram Valamehr
8 Jan 2021
Chief Development Officer
Sell
872
$115.80
$100.98K
Bahram Valamehr
8 Jan 2021
Chief Development Officer
Sell
2,451
$117.15
$287.14K
Bahram Valamehr
8 Jan 2021
Chief Development Officer
Sell
2,756
$117.60
$324.10K
J Scott Wolchko
8 Jan 2021
President and CEO
Sell
1,469
$114.76
$168.58K
J Scott Wolchko
8 Jan 2021
President and CEO
Sell
8,515
$115.80
$986.03K
J Scott Wolchko
8 Jan 2021
President and CEO
Sell
23,932
$117.15
$2.80M
J Scott Wolchko
8 Jan 2021
President and CEO
Sell
26,904
$117.60
$3.16M
J Scott Wolchko
17 Dec 2020
President and CEO
Sold after exercise
100
$93.44
$9.34K
J Scott Wolchko
17 Dec 2020
President and CEO
Sold after exercise
2,796
$92.94
$259.87K
J Scott Wolchko
17 Dec 2020
President and CEO
Sold after exercise
13,936
$91.77
$1.28M
J Scott Wolchko
17 Dec 2020
President and CEO
Sold after exercise
3,168
$90.98
$288.23K
Bahram Valamehr
14 Dec 2020
Chief Development Officer
Sold after exercise
100
$102.75
$10.28K
Bahram Valamehr
14 Dec 2020
Chief Development Officer
Sold after exercise
1,006
$102.06
$102.68K
Bahram Valamehr
14 Dec 2020
Chief Development Officer
Sold after exercise
400
$100.97
$40.39K
Bahram Valamehr
14 Dec 2020
Chief Development Officer
Sold after exercise
3,822
$99.77
$381.32K
Bahram Valamehr
14 Dec 2020
Chief Development Officer
Sold after exercise
3,148
$98.80
$311.01K
Bahram Valamehr
14 Dec 2020
Chief Development Officer
Sold after exercise
2,946
$97.70
$287.81K
Bahram Valamehr
14 Dec 2020
Chief Development Officer
Sold after exercise
11,765
$96.65
$1.14M
Bahram Valamehr
14 Dec 2020
Chief Development Officer
Sold after exercise
1,813
$95.89
$173.86K
Daniel D Shoemaker
16 Nov 2020
Chief Scientific Officer
Sell
14,781
$52.40
$774.51K
Daniel D Shoemaker
16 Nov 2020
Chief Scientific Officer
Sell
5,287
$51.60
$272.83K
Daniel D Shoemaker
16 Nov 2020
Chief Scientific Officer
Sell
4,932
$50.37
$248.41K
J Scott Wolchko
13 Nov 2020
President and CEO
Sold after exercise
10,154
$51.03
$518.16K
J Scott Wolchko
13 Nov 2020
President and CEO
Sold after exercise
9,846
$51.03
$502.44K
J Scott Wolchko
13 Nov 2020
President and CEO
Sold after exercise
10,000
$51.03
$510.30K
J Scott Wolchko
12 Nov 2020
President and CEO
Sold after exercise
1,864
$54.47
$101.53K
J Scott Wolchko
12 Nov 2020
President and CEO
Sold after exercise
10,846
$53.98
$585.51K
J Scott Wolchko
12 Nov 2020
President and CEO
Sold after exercise
2,088
$52.66
$109.96K
J Scott Wolchko
12 Nov 2020
President and CEO
Sold after exercise
15,202
$51.61
$784.52K
